Insider Trading & Ownership - Ildstad Suzanne

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Ildstad Suzanne
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-06-12
Sale
2023-06-14
6:58 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
44,020 $2.5513 $112,307 5,100,302
(Indirect
Direct)
View
2023-06-07
Sale
2023-06-09
5:41 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
141,062 $2.428 $342,504 5,123,822
(Indirect
Direct)
View
2023-06-05
Sale
2023-06-07
6:24 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
33,390 $2.5262 $84,350 5,264,884
(Indirect
Direct)
View
2023-06-01
Sale
2023-06-05
4:21 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
31,531 $2.5306 $79,793 5,298,274
(Indirect
Direct)
View
2023-04-21
Sale
2023-04-25
5:50 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
15,004 $2.3481 $35,231 5,329,805
(Indirect
Direct)
View
2023-04-19
Sale
2023-04-21
07:57 am
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
68,743 $2.2747 $156,369 5,344,809
(Indirect
Direct)
View
2023-04-17
Sale
2023-04-19
09:22 am
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
148,982 $2.1434 $319,334 5,413,552
(Indirect
Direct)
View
2023-03-17
Sale(A)
2023-04-07
4:25 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
10,436 $2.0643 $21,543 5,562,534
(Indirect
Direct)
View
2023-03-03
Sale(A)
2023-04-07
4:23 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
6,806 $2.0559 $13,992 5,572,970
(Indirect
Direct)
View
2023-03-01
Sale(A)
2023-04-07
4:21 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
29 $2.05 $59 5,579,776
(Indirect
Direct)
View
2023-02-21
Sale(A)
2023-04-07
4:19 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
3,500 $2.0529 $7,185 5,579,805
(Indirect
Direct)
View
2023-02-16
Sale(A)
2023-04-07
4:17 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
6,551 $2.0525 $13,446 5,583,305
(Indirect
Direct)
View
2023-03-17
Sale
2023-03-20
4:36 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
10,436 $2.0643 $21,543 5,562,534
(Indirect
Direct)
View
2023-03-03
Sale
2023-03-07
4:58 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
6,806 $2.0559 $13,992 5,572,970
(Indirect
Direct)
View
2023-03-01
Sale
2023-03-02
5:26 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
29 $2.05 $59 5,579,776
(Indirect
Direct)
View
2023-02-21
Sale
2023-02-23
5:01 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
3,500 $2.0529 $7,185 5,579,805
(Indirect
Direct)
View
2023-02-16
Sale
2023-02-21
11:16 am
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
6,551 $2.0525 $13,446 5,583,305
(Indirect
Direct)
View
2022-08-22
Sale
2022-08-23
7:43 pm
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Chief Scientific Officer
525,000 $2.8 $1,470,000 5,589,856
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-13
Option Award
2023-06-14
6:58 pm
N/A
2033-06-13
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Director
20,500 $0 5,100,302
(Direct)
View
2021-11-17
Gift
2022-02-02
6:04 pm
N/A
N/A
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Chief Scientific Officer
1,200,000 $0 6,264,856
(Direct)
View
2022-02-01
Option Award
2022-02-02
6:04 pm
N/A
2032-01-31
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Chief Scientific Officer
150,000 $0 6,264,856
(Direct)
View

Ownership
2021-05-06
9:16 pm
N/A
N/A
Talaris Therapeutics Inc. TALS Ildstad Suzanne
Chief Scientific Officer
10% Owner
0 $0 6,114,856
(Direct)
View
(A) Indicate amendment filing.